Thursday, June 23, 2016

BRIEF-Boston Biomedical announces first orphan drug designation for Napabucasin in gastric/gej cancer

* Boston Biomedical announces first orphan drug designation

for Napabucasin in gastric/gej cancer

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)